Midazolam Hydrochloride Inje · #14 of 35 active shortages by FDA posting duration
Brand: MIDAZOLAM
FDA lists Midazolam Hydrochloride Inje as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Midazolam Hydrochloride Injection: Active Shortage
Available 30 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Midazolam Hydrochloride Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)
- Package NDC
- 63323-411-25
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 2, 2020
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anesthesia, Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Full Drug Profile
midazolam
Side effects, interactions, warnings & more
Nearby, Other Midazolam Shortage Records
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
Midazolam Hydrochloride Injection
Gland Pharma Limited
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.